Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

Glennon, R. A., Titeler, M., & MCKENNEY, J. D. J. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90436-3 · Cited by 635 · see citing works

Tricyclic Antidepressants: Long-Term Treatment Increases Responsivity of Rat Forebrain Neurons to Serotonin

de Montigny, C., & Aghajanian, G. K. (1978) · Science · doi:10.1126/science.725608 · Cited by 477 · see citing works

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

Titeler, M., Lyon, R. A., & Glennon, R. A. (1988) · Psychopharmacology · doi:10.1007/bf00176847 · Cited by 343 · see citing works

Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression

Randrup, A. A., & Br�strup, C. (1977) · Psychopharmacology · doi:10.1007/bf00492370 · Cited by 263 · see citing works

ehavioural evidence for supersensitivtiy of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine

Spyraki, C., & Fibiger, H. C. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90531-8 · Cited by 240 · see citing works

Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity

Serra, G., Argiolas, A., Klimek, V., Fadda, F., & Gessa, G. L. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90573-3 · Cited by 191 · see citing works

The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist states

Creese, I., Burt, D. R., & Snyder, S. H. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90118-6 · Cited by 169 · see citing works

Lithium and serotonin function: implications for the serotonin hypothesis of depression

Price, L. H., Ds, C., Delgado, P. L., & Heninger, G. R. (1990) · Psychopharmacology · doi:10.1007/bf02245781 · Cited by 162 · see citing works

Chronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans

Bonson, K. R. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00145-4 · Cited by 157 · see citing works

Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.

Sanders‐Bush, E., Burris, K. D., & Knoth, K. M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22189-9 · Cited by 155 · see citing works

Do classical hallucinogens act as 5-HT2 agonists or antagonists?

Glennon, R. A. (1991) · PubMed · Cited by 136 · see citing works

Hallucinogenic drug interactions at human brain 5-HT2 receptors: Implications for treating LSD-induced hallucinogenesis

Sadzot, B., Baraban, J. M., Glennon, R. A., Lyon, R. A., Leonhardt, S., Jan, C.-R., & Titeler, M. (1989) · Psychopharmacology · doi:10.1007/bf00441948 · Cited by 132 · see citing works

LSD as an agonist of dopamine receptors in the striatum

Pieri, L., Pieri, M., & Haefely, W. E. (1974) · Nature · doi:10.1038/252586a0 · Cited by 127 · see citing works

Binding Interactions of Lysergic Acid Diethylamide and Related Agents with Dopamine Receptors in the Brain

Burt, D. R., Creese, I., & Snyder, S. H. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10799-2 · Cited by 108 · see citing works

Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment.

Wang, R. Y., & Aghajanian, G. K. (1980) · PubMed · Cited by 107 · see citing works

Failure of chronic lithium treatment to block tricyclic antidepressant-induced 5-HT supersensitivity

Gallager, D. W., & Bunney, W. E. (1979) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00498454 · Cited by 80 · see citing works

Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures

Appel, J. B., White, F. J., & Holohean, A. M. (1982) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(82)90036-7 · Cited by 76 · see citing works

Effect of chronic tricyclic antidepressant treatment on the serotoninergic autoreceptor

Blier, P. U., & de Montigny, C. (1980) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00504527 · Cited by 73 · see citing works

The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders

Salomon, R. M., Miller, H., Delgado, P. L., & Charney, D. S. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199311002-00006 · Cited by 67 · see citing works

Alterations in the behavioral effects of LSD by pretreatment with p-chlorophenylalanine and ?-methyl-p-tyrosine

Appel, J. B., Lovell, R. A., & Freedman, D. X. (1970) · Psychopharmacology · doi:10.1007/bf00402765 · Cited by 62 · see citing works

EFFECT OF CHRONIC TREATMENT WITH TRICYCLIC ANTIDEPRESSANT DRUGS ON IDENTIFIED BRAIN NORADRENERGIC AND SEROTONERGIC NEURONS

Svensson, T. H. (1980) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.1980.61.s280.121 · Cited by 62 · see citing works

Single and combined effects of desimipramine and lithium on serotonergic receptor number and second messenger function in rat brain.

Newman, M. E., Drummer, D., & Lerer, B. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20016-7 · Cited by 56 · see citing works

Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants

Hrdina, P. D. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90429-8 · Cited by 51 · see citing works

Repeated Administration of Antidepressants Enhances Agonist Affinity for Mesolimbic D2-Receptors

Klimek, V., & Maj, J. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06525.x · Cited by 49 · see citing works

Imipramine Hydrochloride

Gershon, S. (1962) · Archives of General Psychiatry · doi:10.1001/archpsyc.1962.01710190098011 · Cited by 49 · see citing works

Human hallucinogen interactions with drugs affecting serotonergic neurotransmission.

Strassman, R. J. (1992) · PubMed · Cited by 41 · see citing works

Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus

Winter, J. C., & Rabin, R. A. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90074-3 · Cited by 40 · see citing works

LSD-25 action in normal subjects treated with a monoamine oxidase inhibitor

Resnick, O., Krus, D. M., & Raskin, M. (1964) · Life Sciences · doi:10.1016/0024-3205(64)90037-2 · Cited by 39 · see citing works

Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro

Sharp, T., Bramwell, S., Lambert, P., et al. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90111-n · Cited by 38 · see citing works

Chronic lithium: desensitization of autoreceptors mediating serotonin release

Wang, H.-Y., & Friedman, E. (1988) · Psychopharmacology · doi:10.1007/bf00174681 · Cited by 38 · see citing works

Monoamine Oxidase Inhibitors as Antidepressants

Kline, N. S., & Cooper, T. B. (1980) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-67538-6_17 · Cited by 36 · see citing works

Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist

Maj, J., Rogóż, Z., Skuza, G., & Sowińska, H. (1989) · Journal of Neural Transmission · doi:10.1007/bf01247108 · Cited by 35 · see citing works

The use of monoamine oxidase inhibitors in schizophrenia.

Brenner, R., & Shopsin, B. (1980) · PubMed · Cited by 29 · see citing works

Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex

CUMMINS, J. T., von Euler, G., Fuxé, K., et al. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90289-8 · Cited by 27 · see citing works

Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats

Mousseau, D. D., & Greenshaw, A. J. (1989) · Journal of Neural Transmission · doi:10.1007/bf01250645 · Cited by 22 · see citing works

Blocking of LSD reaction by premedication with Niamid.

Grof, S., & Dytrych, Z. (1965) · PubMed · Cited by 17 · see citing works

Decreased Number of Benzodiazepine Receptors in Frontal Cortex of Rat Brain Following Long‐Term Lithium Treatment

Hetmar, O., Nielsen, M. B., & Bræstrup, C. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb11830.x · Cited by 14 · see citing works

Study of the role of serotonin in lithium action using shock-elicited fighting.

Jl, M., Sheard, M. H., & Kosten, T. A. (1979) · PubMed · Cited by 8 · see citing works

Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP)

Cunningham, K. A., Carroll, B., & Appel, J. B. (1986) · Psychopharmacology · doi:10.1007/bf00175206 · Cited by 7 · see citing works

Disruption of FR-40 by 5-HT agonists. I. Effects of chronic imipramine or trazodone

Shukla, R., Dave, V., MacKenzie-Taylor, D. R., & Rech, R. H. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90311-0 · Cited by 3 · see citing works

Human hallucinogen research: guidelines for safety

Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203 · see citing works

Serotonin and brain function: a tale of two receptors

Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · see citing works

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

Carhart-Harris, R. L., & Goodwin, G. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.84 · Cited by 706 · see citing works

The pharmacology of lysergic acid diethylamide: A review

Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00059.x · Cited by 455 · see citing works

Psychiatry & the psychedelic drugs. Past, present & future

Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.040 · Cited by 343 · see citing works

Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects

Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00014 · Cited by 224 · see citing works

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects

Becker, A. M., Holze, F., Grandinetti, T., Klaiber, A., Toedtli, V. E., Kolaczynska, K. E., Duthaler, U., Varghese, N., Eckert, A., Grünblatt, E., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2487 · Cited by 184 · see citing works

Serotonin toxicity of serotonergic psychedelics

Malcolm, B., & Thomas, K. (2022) · Psychopharmacology · doi:10.1007/s00213-021-05876-x · Cited by 138 · see citing works

Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research

Bender, D., & Hellerstein, D. J. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06049-6 · Cited by 88 · see citing works

The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges

Scala, M., Fabbri, C., Fusar-Poli, P., Di Lorenzo, G., Ferrara, M., Amerio, A., Fusar-Poli, L., Pichiecchio, A., Asteggiano, C., Menchetti, M., et al. (2024) · CNS Spectrums · doi:10.1017/s1092852924002268 · Cited by 9 · see citing works

Treatment of amitriptyline poisoning with ovine antibody to tricyclic antidepressants

Heard, K. J., O’Malley, G. F., & Dart, R. C. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03358-9 · Cited by 26 · see citing works

Lysergic acid diethylamide: LSD

Seidler, R. (2001) · Current therapeutics · Cited by 1 · see citing works

2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug

Snyder, S. H., Faillace, L. A., & Hollister, L. E. (1967) · Science · doi:10.1126/science.158.3801.669 · Cited by 146 · see citing works

An Animal Behavior Model for Studying the Actions of LSD and Related Hallucinogens

Jacobs, B. L., Trulson, M. E., & Stern, W. C. (1976) · Science · doi:10.1126/science.982043 · Cited by 74 · see citing works

Microcrystalloptic tests for lysergic acid diethylamide and other hallucinogens

GENEST, K., & Lowry, L. J. (1970) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1970.tb08449.x · Cited by 2 · see citing works